Skip to main content
SpringerLink
Log in

Understanding tumor lysis syndrome

  • Understanding the Disease
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Howard SC, Jones DP, Pui C-H (2011) The tumor lysis syndrome. N Engl J Med 364:1844–1854

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Darmon M, Vincent F, Camous L et al (2013) Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique. Br J Haematol 162:489–497

    Article  CAS  PubMed  Google Scholar 

  3. Soares M, Feres GA, Salluh JIF (2009) Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome. Clin Sao Paulo Braz 64:479–481

    Article  Google Scholar 

  4. Canet E, Zafrani L, Lambert J et al (2013) Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS ONE 8:e55870

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Darmon M, Guichard I, Vincent F et al (2010) Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma 51:221–227

    Article  PubMed  Google Scholar 

  6. Cairo MS, Bishop M (2004) Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 127:3–11

    Article  PubMed  Google Scholar 

  7. Howard SC, Trifilio S, Gregory TK et al (2016) Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review. Ann Hematol 95:563–573

    Article  CAS  PubMed  Google Scholar 

  8. Cairo MS, Coiffier B, Reiter A et al (2010) Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 149:578–586

    Article  CAS  PubMed  Google Scholar 

  9. Jones GL, Will A, Jackson GH et al (2015) Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Br J Haematol 169:661–671

    Article  PubMed  Google Scholar 

  10. Conger JD, Falk SA (1977) Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy. J Clin Invest 59:786–793

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Cortes J, Moore JO, Maziarz RT et al (2010) Control of Plasma Uric acid in adults at risk for tumor lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone—results of a multicenter phase III study. J Clin Oncol 28:4207–4213

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Feng X, Dong K, Pham D et al (2013) Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis. J Clin Pharm Ther 38:301–308

    Article  CAS  PubMed  Google Scholar 

  13. Boles JM, Dutel JL, Briere J et al (1984) Acute renal failure caused by extreme hyperphosphatemia after chemotherapy of an acute lymphoblastic leukemia. Cancer 53:2425–2429

    Article  CAS  PubMed  Google Scholar 

  14. Kanfer A, Richet G, Roland J, Chatelet F (1979) Extreme hyperphosphataemia causing acute anuric nephrocalcinosis in lymphosarcoma. Br Med J 1:1320–1321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Agha-Razii M, Amyot SL, Pichette V et al (2000) Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia. Clin Nephrol 54:59–63

    CAS  PubMed  Google Scholar 

  16. Mamez A-C, Raffoux E, Chevret S et al (2016) Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia. Leuk Lymphoma 57:2281–2288

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Intensive Care Unit, Hopital Saint Louis, Assistance des Hôpitaux de Paris, Paris University, Paris, France

    Lara Zafrani & Michael Darmon

  2. INSERM, UMR 976, Human Immunology Pathophysiology and Immunotherapy, Hôpital Saint Louis, Paris, France

    Lara Zafrani

  3. Intensive Care Unit, Nantes University Hospital, Nantes, France

    Emmanuel Canet

Authors
  1. Lara Zafrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanuel Canet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Darmon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lara Zafrani.

Ethics declarations

Conflicts of interest

L Zafrani has received a research grant from Jazz Pharma. Dr. Darmon reports grants from MSD, personal fees from Gilead-Kite, personal fees from Astelas, outside the submitted work; Dr. CANET reports personal fees from GILEAD, outside the submitted work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zafrani, L., Canet, E. & Darmon, M. Understanding tumor lysis syndrome. Intensive Care Med 45, 1608–1611 (2019). https://doi.org/10.1007/s00134-019-05768-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-019-05768-x

Search

Navigation